Paul Hoff

Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer

Leonard B. Saltz, Heinz‐Josef Lenz, Howard S. Höchster et al. · Journal of Clinical Oncology · 2005 · 182 citations

Medicine, Oncology, Pharmacology +17

Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis

Manuel B. Graeber, Siegfried Kösel, Rupert Egensperger et al. · Neurogenetics · 1997 · 175 citations

Medicine, Molecular Genetics, Neurology +14

Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart.

Yasuo Tamura, Edward M. Driscoll, Paul Hoff et al. · Circulation Research · 1988 · 126 citations · Full text

Medicine, Cardiology, Biocompatibility +13

Drug‐Induced Sleep Endoscopy and Surgical Outcomes: A Multicenter Cohort Study

Katherine K. Green, David T. Kent, Mark A. D׳Agostino et al. · The Laryngoscope · 2018 · 126 citations · Full text

Medicine, Otolaryngology, Surgery +17

Clinical Outcomes and Complications Associated with TORS for OSAHS: A Benchmark for Evaluating an Emerging Surgical Technology in a Targeted Application for Benign Disease

Claudio Vicini, Filippo Montevecchi, Aldo Campanini et al. · ORL · 2014 · 102 citations

Medicine, Surgery, General Surgery +16